Cargando…
The Insulin-Like Growth Factor 2 mRNA Binding Protein IMP2/IGF2BP2 is Overexpressed and Correlates with Poor Survival in Pancreatic Cancer
The insulin-like growth factor 2 (IGF2) mRNA binding protein IMP2 (IGF2BP2) is an oncogenic protein known to be overexpressed in different tumor types. Pancreatic cancer is a very lethal cancer that requires early diagnosis and new treatment options. The aim of our study was to investigate the role...
Autores principales: | Dahlem, Charlotte, Barghash, Ahmad, Puchas, Philip, Haybaeck, Johannes, Kessler, Sonja M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651604/ https://www.ncbi.nlm.nih.gov/pubmed/31261900 http://dx.doi.org/10.3390/ijms20133204 |
Ejemplares similares
-
Elevated expression of the IGF2 mRNA binding protein 2 (IGF2BP2/IMP2) is linked to short survival and metastasis in esophageal adenocarcinoma
por: Barghash, Ahmad, et al.
Publicado: (2016) -
IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer
por: Kessler, Sonja M., et al.
Publicado: (2017) -
The insulin-like growth factor 2 (IGF2) mRNA-binding protein p62/IGF2BP2-2 as a promoter of NAFLD and HCC?
por: Simon, Yvette, et al.
Publicado: (2014) -
Comment on: The m6A Reader IGF2BP2 Regulates Macrophage Phenotypic Activation and Inflammatory Diseases by Stabilizing TSC1 and PPARγ
por: Schymik, Hanna S., et al.
Publicado: (2022) -
IMP2/p62 induces genomic instability and an aggressive hepatocellular carcinoma phenotype
por: Kessler, S M, et al.
Publicado: (2015)